On April 23, 2024, the Federal Trade Commission (FTC) approved the proposed ban on non-compete agreements.
Under the new rule, existing non-competes for senior executives remain enforceable....more
6/14/2024
/ Employment Contract ,
Federal Trade Commission (FTC) ,
Final Rules ,
Health Care Providers ,
Healthcare Facilities ,
Hospitals ,
Non-Compete Agreements ,
Nonprofits ,
Physicians ,
Regulatory Authority ,
Restrictive Covenants
The Department of Health and Human Services has published a proposed rule to address short payments on drug acquisition costs for 340B hospitals from 2018 to September 2022.
On June 15, 2022, the Supreme Court unanimously...more
On January 30, 2023, President Biden announced that both the COVID-19 national emergency and the public health emergency (PHE) will end May 11, 2023. This announcement has left many healthcare providers considering how the...more
2/21/2023
/ Centers for Medicare & Medicaid Services (CMS) ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Emergency Rooms ,
EMTALA ,
Health Care Providers ,
Hospitals ,
Infectious Diseases ,
Medicaid ,
Medicare ,
Public Health ,
Public Health Emergency ,
Waivers
Pursuant to the Supreme Court’s decision in AHA et al. v. Becerra, decided on June 15, 2022, the U.S. Court for the District of Columbia ruled in September that the Centers for Medicare & Medicaid Services (CMS) must...more
On Friday, June 24th, the Supreme Court unanimously agreed with the American Hospital Association (AHA) and 340B hospitals regarding their challenge to outpatient prescription drug reimbursement methodologies issued by the...more
6/15/2022
/ American Hospital Association et al v Becerra Secretary Of Health And Human Services et al ,
Centers for Medicare & Medicaid Services (CMS) ,
Drug Pricing ,
Health Care Providers ,
Hospitals ,
Medicare ,
Outpatient Prospective Payment System (OPPS) ,
Prescription Drugs ,
Reimbursements ,
SCOTUS ,
Section 340B